Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinomaSixue Liu, Roger S. Lo, Shirley H. Lomeli et al.|Cell Reports Medicine|2021Cited by 57
A Th17 signature correlates with response to dual CTLA-4 and PD-1 blockade in metastatic renal cell carcinomaSilvia Guglietta, Carsten Krieg|medRxiv|2025Cited by 0